Bring your portfolio to life with these fantastic ASX healthcare shares

CSL Limited (ASX:CSL) and this ASX healthcare share could bring your portfolio to life. Here’s what you nee to know about them…
The post Bring your portfolio to life with these fantastic ASX healthcare shares appeared first on The Motley Fool Australia. –

increase in asx medical software share price represented by doctor making excited hands up gesture

Because of ageing and growing populations, better technologies and treatments, and increasing chronic disease burden, demand for healthcare services is expected to continue to increase over the long term.

This bodes well for healthcare shares, positioning them perfectly for growth over the 2020s and beyond. With that in mind, I have picked out two healthcare shares that are highly rated right now:

CSL Limited (ASX: CSL)

CSL is one of the world’s leading biotechnology companies, comprising the CSL Behring and Seqirus businesses. CSL Behring is the global leader in plasma therapies, whereas Seqirus is the world’s second largest influenza vaccines business.

Both businesses appear well-placed for growth over the long term. For CSL Behring, this is due to robust demand for its life-saving immunoglobulins products and its highly promising research and development pipeline. The latter is filled with a good number of potentially lucrative products.

Supporting this growth will be its Seqirus business, which is expected to experience a surge in demand for seasonal flu vaccines because of the pandemic.

And while plasma collection headwinds are likely to weigh on the company’s overall growth in the immediate term, once the pandemic passes, collections will become easier and this headwind will ease.

One broker that is positive on CSL is Citi. Last week it upgraded its shares to a buy rating with a $310 price target. This compares to the current CSL share price of $261.00.

ResMed Inc. (ASX: RMD)

Another healthcare share which is highly rated is medical device company ResMed.

ResMed aims to change lives by developing, manufacturing, and distributing innovative medical devices and cloud-based software solutions that better diagnose, treat, and manage sleep-disordered breathing, chronic obstructive pulmonary disease (COPD), and other key chronic diseases.

These are lucrative markets for the company to target. Management estimates that there are hundreds of millions of sufferers of both sleep apnoea and COPD globally.

In addition to its industry-leading hardware, the company has a burgeoning digital health ecosystem. This ecosystem reached over 12 million cloud connectable medical devices in 2020, providing ResMed with strong recurring revenues and a material amount of high quality data.

Analysts at Morgans are bullish on the company. They recently retained their add rating and put a price target of $30.09 on its shares. This compares to the current ResMed share price of $25.03.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Bring your portfolio to life with these fantastic ASX healthcare shares appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!